Metabolic Diseases
Metabolic Diseases is a key segment within the Healthcare sector, comprising 582+ companies actively operating in this space.
This segment represents businesses focused on specific activities and services within Healthcare. Companies in this segment share common characteristics, market positioning, and often face similar challenges and opportunities.
Browse the comprehensive directory of Metabolic Diseases companies to access detailed profiles, financial information, funding rounds, investor details, and other critical business intelligence for research, due diligence, and market analysis.
Discover leading companies in this segment, ranked by company performance and market presence.
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
Developer of small-molecule drugs
Developer of cortisol modulators for the treatment of various diseases
Developer of therapies for the treatment of endocrine-related diseases and cancers
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
Developer of small molecule therapeutics for endocrine and CNS disorders
Solutions for biomarker discovery and diagnostic testing are provided.
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
Biologics are developed for cardio-metabolic and liver diseases.
Developing a long-term therapeutic approach to prevent hypoglycemia in patients with diabetes
Develops small molecule drugs for the treatment of cardiovascular and metabolic diseases and non-alcoholic steatohepatitis
Endoscopic procedures for type-2 diabetes treatment are developed.
Disease-modifying therapies for metabolic diseases are developed.
Small molecule therapeutics for metabolic disorders are developed.
Drugs for rare endocrine diseases are developed and advanced.
Provider of small molecule based drug for inflammatory kidney disease
Therapeutic devices for obesity and GI disorders are developed.
Developer of therapies for treating nonalcoholic steatohepatitis and other liver and metabolic disorders
Therapeutics for infectious and autoimmune diseases are developed.
Explore Companies in Metabolic Diseases
Access detailed company profiles, financial data, funding information, and more for all companies in this segment.
View All Companies